[CAS NO. 473719-41-4]  AMG 487

Ships within Stock Price Qty Total
$0.00
$0.00
Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [473719-41-4]

Store
Catalog
SLK-S8682
Brand
Selleck
CAS
473719-41-4

DESCRIPTION [473719-41-4]

Overview

MDLMFCD11111772
Molecular Weight603.59
Molecular FormulaC32H28F3N5O4
SMILESO=C(N([C@@H](C1=NC2=NC=CC=C2C(N1C3=CC=C(OCC)C=C3)=O)C)CC4=CC=CN=C4)CC5=CC=C(OC(F)(F)F)C=C5

For research use only.

Storage

3 years,-20°C,powder
1 years,-80°C,in solvent

Shipping

Room temperature shipping(Stability testing shows this product can be shipped without any cooling measures.)

Preparing Stock Solutions

1 mg5 mg10 mg
1 mM1.6568 mL8.2838 mL16.5675 mL
5 mM0.3314 mL1.6568 mL3.3135 mL
10 mM0.1657 mL0.8284 mL1.6568 mL
50 mM0.0331 mL0.1657 mL0.3314 mL

Description

AMG 487 is an orally active and selective antagonist that inhibits the binding of IP-10 (CXCL10) and ITAC (CXCL11) to CXCR3 with IC50 of 8.0 nM and 8.2 nM, respectively.

Targets

CXCR3-CXCL10 [1]
(Cell-free assay)
CXCR3-CXCL11 [1]
(Cell-free assay)
8.0 nM8.2 nM

In vitro

AMG487 is the targeted blocker of chemokine receptor CXCR3 and improves inflammatory symptoms by blocking the inflammatory cycle. AMG487 significantly affects DC maturity in vitro and function leading to impaired T cell activation, inducing DCs to have characteristics similar to tolerogenic DCs. AMG487 may directly play an immunomodulatory role during DC development and functional shaping.